Gorka Orive

Gorka Orive's AcademicInfluence.com Rankings

Gorka Orive

Medical

#2534

World Rank

#2962

Historical Rank

Pharmacology

#266

World Rank

#312

Historical Rank

medical Degrees

Download Badge

Medical

Gorka Orive's Degrees

PhD Pharmacology University of the Basque Country
Masters Pharmaceutical Sciences University of the Basque Country
Bachelors Pharmacy University of the Basque Country

Why Is Gorka Orive Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gorka Orive's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cell encapsulation: Promise and progress (2003) (557)
New insights into and novel applications for platelet-rich fibrin therapies. (2006) (519)
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. (2007) (497)
Biomaterials for promoting brain protection, repair and regeneration (2009) (380)
A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. (2012) (362)
History, challenges and perspectives of cell microencapsulation. (2004) (346)
Platelet-Rich Therapies in the Treatment of Orthopaedic Sport Injuries (2009) (340)
Cell microencapsulation technology: towards clinical application. (2008) (332)
Microcapsules and microcarriers for in situ cell delivery. (2010) (326)
Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. (2006) (324)
Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. (2008) (288)
Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. (2002) (250)
Fibroblastic response to treatment with different preparations rich in growth factors (2009) (240)
Self‐Healing Hydrogels: The Next Paradigm Shift in Tissue Engineering? (2019) (228)
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature. (2005) (220)
Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. (2013) (219)
Gelatin as Biomaterial for Tissue Engineering. (2017) (207)
Drug delivery in biotechnology: present and future. (2003) (204)
Multiscale requirements for bioencapsulation in medicine and biotechnology. (2009) (204)
Delivering growth factors for therapeutics. (2008) (202)
Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. (2006) (188)
Potential of endogenous regenerative technology for in situ regenerative medicine. (2010) (183)
Perspectives and challenges in regenerative medicine using plasma rich in growth factors. (2012) (183)
Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review (2020) (155)
Quantum dots in biomedical applications. (2019) (147)
Toward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration (2014) (144)
Influence of implant length, diameter, and geometry on stress distribution: a finite element analysis. (2010) (139)
Cell encapsulation: technical and clinical advances. (2015) (137)
3D Bioprinting in Skeletal Muscle Tissue Engineering. (2019) (134)
Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D. (2012) (133)
Antibacterial effect of plasma rich in growth factors (PRGF®‐Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains (2012) (133)
Advances and Future Perspectives in 4D Bioprinting (2018) (131)
Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies (2015) (125)
Cell microencapsulation technology for biomedical purposes: novel insights and challenges. (2003) (122)
Early SARS-CoV-2 outbreak detection by sewage-based epidemiology (2020) (121)
Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. (2011) (116)
Application of cell encapsulation for controlled delivery of biological therapeutics. (2014) (115)
Leukocyte Inclusion within a Platelet Rich Plasma-Derived Fibrin Scaffold Stimulates a More Pro-Inflammatory Environment and Alters Fibrin Properties (2015) (111)
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. (2010) (110)
Short implants in maxillae and mandibles: a retrospective study with 1 to 8 years of follow-up. (2010) (107)
Biocompatibility evaluation of different alginates and alginate-based microcapsules. (2005) (106)
Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. (2006) (105)
Plasma rich in growth factors promotes bone tissue regeneration by stimulating proliferation, migration, and autocrine secretion in primary human osteoblasts. (2013) (104)
Platelet-Rich Plasma: Preparation and Formulation (2012) (103)
Survival of different cell lines in alginate-agarose microcapsules. (2003) (103)
Proton transport inhibitors as potentially selective anticancer drugs. (2009) (102)
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin (2017) (101)
Five-year clinical evaluation of short dental implants placed in posterior areas: a retrospective study. (2008) (99)
The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study. (2009) (98)
Techniques: new approaches to the delivery of biopharmaceuticals. (2004) (98)
Bioactive cell-hydrogel microcapsules for cell-based drug delivery. (2009) (97)
Nanotherapeutic approaches for brain cancer management. (2014) (95)
Morphogen and proinflammatory cytokine release kinetics from PRGF-Endoret fibrin scaffolds: evaluation of the effect of leukocyte inclusion. (2015) (94)
Plasma rich in growth factors (PRGF-Endoret) stimulates corneal wound healing and reduces haze formation after PRK surgery. (2013) (88)
5-year clinical experience with BTI dental implants: risk factors for implant failure. (2008) (84)
Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts. (2015) (84)
Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. (2012) (83)
Bilateral sinus elevation evaluating plasma rich in growth factors technology: a report of five cases. (2012) (78)
Implant survival and crestal bone loss around extra-short implants supporting a fixed denture: the effect of crown height space, crown-to-implant ratio, and offset placement of the prosthesis. (2014) (78)
Clinical, radiographical, and histological outcomes of plasma rich in growth factors in extraction socket: a randomized controlled clinical trial (2015) (77)
Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation. (2003) (75)
Progress of gelatin-based 3D approaches for bone regeneration (2017) (74)
Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. (2013) (74)
Biomaterials in cell microencapsulation. (2010) (74)
Encapsulated cell therapy for neurodegenerative diseases: from promise to product. (2014) (73)
Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration (2017) (73)
High‐throughput proteomic characterization of plasma rich in growth factors (PRGF–Endoret)‐derived fibrin clot interactome (2015) (73)
Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. (2005) (71)
Therapeutic cell encapsulation: ten steps towards clinical translation. (2013) (71)
Sulfated polysaccharide-based scaffolds for orthopaedic tissue engineering. (2019) (71)
The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study (2017) (70)
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression. (2021) (69)
Blending Electronics with the Human Body: A Pathway toward a Cybernetic Future (2018) (67)
Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. (2007) (66)
Biomaterial-based technologies for brain anti-cancer therapeutics and imaging. (2010) (65)
Long-term retrospective evaluation of short implants in the posterior areas: clinical results after 10-12 years. (2014) (64)
Comparative study of microcapsules elaborated with three polycations (PLL, PDL, PLO) for cell immobilization (2005) (64)
A multicentre placebo-controlled randomised clinical trial of antibiotic prophylaxis for placement of single dental implants. (2009) (61)
Retrospective study of short and extra-short implants placed in posterior regions: influence of crown-to-implant ratio on marginal bone loss. (2015) (61)
Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid (2012) (60)
Encapsulated cell technology: from research to market. (2002) (60)
Effects of calcium-modified titanium implant surfaces on platelet activation, clot formation, and osseointegration. (2015) (60)
Efficacy and safety of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis. (2014) (58)
In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules. (2007) (57)
Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases (2016) (57)
A lateral approach for sinus elevation using PRGF technology. (2009) (57)
A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma (2016) (56)
Recent advances in gelatin-based therapeutics (2019) (55)
Intranasal Delivery of Plasma and Platelet Growth Factors Using PRGF-Endoret System Enhances Neurogenesis in a Mouse Model of Alzheimer’s Disease (2013) (54)
Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease. (2015) (52)
Multifunctional Antimicrobial Nanofibre Dressings Containing ε-Polylysine for the Eradication of Bacterial Bioburden and Promotion of Wound Healing in Critically Colonized Wounds. (2020) (52)
Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop. (2014) (52)
Engineering a Clinically Translatable Bioartificial Pancreas to Treat Type I Diabetes. (2018) (51)
Cellular acidification as a new approach to cancer treatment and to the understanding and therapeutics of neurodegenerative diseases. (2017) (51)
Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangers. (2007) (51)
Clinical evaluation of split-crest technique with ultrasonic bone surgery for narrow ridge expansion: status of soft and hard tissues and implant success. (2013) (51)
Implementation of a more physiological plasma rich in growth factor (PRGF) protocol: Anticoagulant removal and reduction in activator concentration (2016) (50)
Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops (2018) (50)
Efficacy of biologically guided implant site preparation to obtain adequate primary implant stability. (2015) (50)
Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. (2009) (50)
Infiltration of plasma rich in growth factors enhances in vivo angiogenesis and improves reperfusion and tissue remodeling after severe hind limb ischemia. (2015) (49)
Pectin Methacrylate (PEMA) and Gelatin-Based Hydrogels for Cell Delivery: Converting Waste Materials into Biomaterials. (2019) (48)
Decreased salivary lactoferrin levels are specific to Alzheimer's disease (2020) (48)
Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts. (2009) (45)
Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months (2013) (45)
Benefits of plasma rich in growth factors (PRGF) in skin photodamage: Clinical response and histological assessment (2015) (44)
PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model. (2016) (44)
Ultrasound‐guided plasma rich in growth factors injections and scaffolds hasten motor nerve functional recovery in an ovine model of nerve crush injury (2017) (44)
A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model. (2013) (44)
Review of Advanced Hydrogel-Based Cell Encapsulation Systems for Insulin Delivery in Type 1 Diabetes Mellitus (2019) (41)
Human-Based Biological and Biomimetic Autologous Therapies for Musculoskeletal Tissue Regeneration. (2017) (41)
Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders (2015) (41)
A biological therapy to osteoarthritis treatment using platelet-rich plasma (2013) (41)
Towards brain-tissue-like biomaterials (2020) (41)
Combinatorial Screening of Nanoclay-Reinforced Hydrogels: A Glimpse of the "Holy Grail" in Orthopedic Stem Cell Therapy? (2018) (40)
An autologous platelet-rich plasma stimulates periodontal ligament regeneration. (2013) (40)
Advances in understanding the role of P-gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects. (2021) (40)
In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. (2006) (40)
Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells. (2001) (40)
Shedding light in the controversial terminology for platelet rich products. (2009) (40)
Advanced nanovehicles for cancer management. (2014) (39)
Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis (2013) (39)
Clinical Outcome of Immediately Loaded Dental Implants Bioactivated With Plasma Rich in Growth Factors: A 5-Year Retrospective Study (2008) (38)
The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome. (2017) (38)
The importance of understanding what is platelet-rich growth factor (PRGF) and what is not. (2011) (38)
Allogeneic Platelet-Rich Plasma: At the Dawn of an Off-the-Shelf Therapy? (2017) (38)
Endogenous regenerative technology using plasma- and platelet-derived growth factors. (2012) (38)
Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells (2010) (37)
Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye (2016) (37)
Endogenous morphogens and fibrin bioscaffolds for stem cell therapeutics. (2013) (37)
Plasma rich in growth factors promotes dermal fibroblast proliferation, migration and biosynthetic activity. (2016) (37)
Advances in the slow freezing cryopreservation of microencapsulated cells (2018) (36)
Enzymatic crosslinked gelatin 3D scaffolds for bone tissue engineering. (2019) (36)
Platelet-Rich Plasma to Improve the Bio-Functionality of Biomaterials (2013) (36)
Plasma rich in growth factors (PRGF-Endoret) reduces neuropathologic hallmarks and improves cognitive functions in an Alzheimer's disease mouse model (2014) (35)
AIE-featured tetraphenylethylene nanoarchitectures in biomedical application: Bioimaging, drug delivery and disease treatment (2021) (35)
Hydrogen ion dynamics and the Na+/H+ exchanger in cancer angiogenesis and antiangiogenesis (2003) (35)
Platelet Rich Plasma and Knee Surgery (2014) (35)
Novel technique for the treatment of the severely atrophied posterior mandible. (2013) (35)
A Perspective on Bioactive Cell Microencapsulation (2012) (34)
Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system. (2010) (33)
Biphasic hydrogels integrating mineralized and anisotropic features for interfacial tissue engineering. (2019) (33)
Treatment of hemimandibular paresthesia in a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) by combining surgical resection and PRGF-Endoret. (2013) (33)
Cryopreservation of microencapsulated murine mesenchymal stem cells genetically engineered to secrete erythropoietin. (2015) (33)
Optimization of 100 μm alginate-poly-L-lysine-alginate capsules for intravitreous administration. (2012) (33)
Advances in cell encapsulation technology and its application in drug delivery (2015) (31)
Graphene oxide increases the viability of C2C12 myoblasts microencapsulated in alginate. (2015) (31)
Design of a composite drug delivery system to prolong functionality of cell-based scaffolds. (2011) (30)
Muscle repair: platelet-rich plasma derivates as a bridge from spontaneity to intervention. (2014) (30)
Controlled Ridge Expansion Using a Two-Stage Split-Crest Technique With Ultrasonic Bone Surgery (2012) (29)
Encapsulation of cells in alginate gels. (2013) (29)
Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders (2018) (29)
Multifunctional hydrogel-based scaffold for improving the functionality of encapsulated therapeutic cells and reducing inflammatory response. (2014) (28)
The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes. (2011) (28)
Micro and nano drug delivery systems in cancer therapyArticle (2005) (28)
Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise. (2021) (28)
Plasma rich in growth factors: the pioneering autologous technology for tissue regeneration. (2011) (28)
Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance (2022) (28)
A new approach for atraumatic implant explantation and immediate implant installation. (2012) (27)
Clinical evaluation of Tiny® 2.5- and 3.0-mm narrow-diameter implants as definitive implants in different clinical situations: a retrospective cohort study. (2010) (27)
Encapsulated VEGF-secreting cells enhance proliferation of neuronal progenitors in the hippocampus of AβPP/Ps1 mice. (2012) (27)
Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage (2015) (27)
Closing regulatory gaps: new ground rules for platelet-rich plasma. (2015) (27)
Alginate Microcapsules Incorporating Hyaluronic Acid Recreate Closer in Vivo Environment for Mesenchymal Stem Cells. (2017) (26)
Emergence of microfluidics for next generation biomedical devices (2022) (25)
Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers. (2015) (24)
Biocompatible oligochitosans as cationic modifiers of alginate/Ca microcapsules. (2005) (24)
Cell microencapsulation technology: Current vision of its therapeutic potential through the administration routes (2017) (24)
3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies (2018) (23)
Graphene oxide enhances alginate encapsulated cells viability and functionality while not affecting the foreign body response (2018) (23)
Hyaluronic acid enhances cell survival of encapsulated insulin‐producing cells in alginate‐based microcapsules (2019) (23)
Assessment of the Behavior of Mesenchymal Stem Cells Immobilized in Biomimetic Alginate Microcapsules. (2015) (22)
Controversies over stem cell research. (2003) (22)
Surgical correction of horizontal bone defect using the lateral maxillary wall: outcomes of a retrospective study. (2014) (22)
Clinical outcome of immediately loaded dental implants bioactivated with plasma rich in growth factors: a 5-year retrospective study. (2008) (22)
The type of platelet-rich plasma may influence the safety of the approach (2014) (22)
Time-dependent release of growth factors from implant surfaces treated with plasma rich in growth factors. (2013) (21)
Microcapsules prepared with different biomaterials to immobilize GDNF secreting 3T3 fibroblasts. (2005) (21)
Biologically active and biomimetic dual gelatin scaffolds for tissue engineering. (2017) (21)
The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors. (2014) (21)
Plasma Rich in Growth Factors Enhances Wound Healing and Protects from Photo-oxidative Stress in Dermal Fibroblasts and 3D Skin Models. (2016) (21)
Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation. (2019) (20)
The synergistic effects of the RGD density and the microenvironment on the behavior of encapsulated cells: in vitro and in vivo direct comparative study. (2014) (20)
Opening new horizons in regenerative dermatology using platelet‐based autologous therapies (2017) (20)
Cryopreservation of Human Mesenchymal Stem Cells in an Allogeneic Bioscaffold based on Platelet Rich Plasma and Synovial Fluid (2017) (20)
A novel personalized 3D injectable protein scaffold for regenerative medicine (2017) (20)
Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseases (2022) (20)
Management of androgenetic alopecia: a comparative clinical study between plasma rich in growth factors and topical minoxidil (2016) (20)
Behaviour and ultrastructure of human bone marrow-derived mesenchymal stem cells immobilised in alginate-poly-l-lysine-alginate microcapsules (2014) (20)
The 3D Bioprinted Scaffolds for Wound Healing (2022) (19)
Evaluation of human serum albumin as a substitute of foetal bovine serum for cell culture. (2006) (19)
Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules. (2009) (19)
Superbugs but no drugs: steps in averting a post-antibiotic era. (2019) (19)
Combinatorial fluorapatite-based scaffolds substituted with strontium, magnesium and silicon ions for mending bone defects. (2020) (19)
Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases (2018) (19)
Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells. (2013) (18)
Biomedical Applications of Immobilized Cells (2006) (18)
Stem cells in alginate bioscaffolds. (2012) (18)
Personalized plasma-based medicine to treat age-related diseases. (2017) (18)
Cell microencapsulation technologies for sustained drug delivery: Latest advances in efficacy and biosafety. (2021) (18)
Can 4D bioprinting revolutionize drug development? (2019) (18)
Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma (2018) (18)
Effects of anti-aggregant, anti-inflammatory and anti-coagulant drug consumption on the preparation and therapeutic potential of plasma rich in growth factors (PRGF) (2015) (17)
Advances in stem cell therapy for cartilage regeneration in osteoarthritis. (2018) (17)
Emerging technologies in the delivery of erythropoietin for therapeutics (2011) (17)
Inactivation of encapsulated cells and their therapeutic effects by means of TGL triple-fusion reporter/biosafety gene. (2013) (16)
Current research in biotechnology: Exploring the biotech forefront (2019) (16)
Cells, Materials, and Fabrication Processes for Cardiac Tissue Engineering (2020) (16)
Progress in the Use of Autologous Regenerative Platelet-based Therapies in Implant Dentistry. (2016) (16)
Hyaluronic Acid Promotes Differentiation of Mesenchymal Stem Cells from Different Sources toward Pancreatic Progenitors within Three-Dimensional Alginate Matrixes. (2019) (16)
Current research in biotechnology: Exploring the biotech forefront (2019) (16)
Progress in Gelatin as Biomaterial for Tissue Engineering (2022) (16)
Two-stage split-crest technique with ultrasonic bone surgery for controlled ridge expansion: a novel modified technique. (2011) (16)
Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology. (2017) (16)
Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology. (2013) (16)
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology (2022) (15)
Finite element analysis of the influence of the offset placement of an implant-supported prosthesis on bone stress distribution. (2009) (15)
Biological effects of plasma rich in growth factors (PRGF) on human endometrial fibroblasts. (2016) (15)
Artificial neural network-based estimation of COVID-19 case numbers and effective reproduction rate using wastewater-based epidemiology (2022) (15)
Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery (2018) (15)
Therapeutic applications of encapsulated cells. (2013) (14)
Cell-Biomaterial Interaction: Strategies To Mimic The Extracellular Matrix (2011) (14)
Therapeutic Applications of Cell Microencapsulation (2010) (14)
Encapsulate this: the do's and don'ts (2014) (14)
Evaluation of different RGD ligand densities in the development of cell-based drug delivery systems (2015) (14)
PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells (2016) (14)
Alginate Microcapsules for Drug Delivery (2018) (13)
Wound healing properties of magnesium mineralized antimicrobial nanofibre dressings containing chondroitin sulphate - a comparison between blend and core-shell nanofibres. (2020) (13)
Drug pollution & Sustainable Development Goals. (2021) (13)
Association of transalveolar sinus floor elevation, platelet rich plasma, and short implants for the treatment of atrophied posterior maxilla (2015) (13)
Two cycles of plasma rich in growth factors (PRGF-Endoret) intra-articular injections improve stiffness and activities of daily living but not pain compared to one cycle on patients with symptomatic knee osteoarthritis (2018) (12)
Drug pollution and pharmacotherapy in psychiatry: A “platypus” in the room (2020) (12)
Mass transfer characteristics of poly-lysine, poly-ornithine and poly-methylene-co-guanidine membrane coated alginate microcapsules (2005) (12)
3D cell-laden polymers to release bioactive products in the eye (2019) (12)
An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS) (2008) (12)
Subconjunctival PRGF Fibrin Membrane as an Adjuvant to Nonpenetrating Deep Sclerectomy: A 2-Year Pilot Study (2017) (12)
Type 1 Diabetes Mellitus reversal via implantation of magnetically purified microencapsulated pseudoislets (2019) (11)
Bioinspired gelatin/bioceramic composites loaded with bone morphogenetic protein-2 (BMP-2) promote osteoporotic bone repair. (2021) (11)
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation (2020) (11)
Hybrid Alginate-Protein-Coated Graphene Oxide Microcapsules Enhance the Functionality of Erythropoietin Secreting C2C12 Myoblasts. (2017) (11)
Design and characterization of calcium alginate microparticles coated with polycations as protein delivery system (2011) (11)
Combating Microbial Contamination with Robust Polymeric Nanofibers: Elemental Effect on the Mussel-Inspired Cross-Linking of Electrospun Gelatin. (2018) (11)
Implant-Guided Vertical Bone Augmentation Around Extra-Short Implants for the Management of Severe Bone Atrophy. (2015) (10)
Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus (2021) (10)
Characterization of an encapsulated insulin secreting human pancreatic beta cell line in a modular microfluidic device (2018) (10)
Use of illicit drugs, alcohol and tobacco in Spain and Portugal during the COVID-19 crisis in 2020 as measured by wastewater-based epidemiology (2022) (10)
Plasma rich in growth factors (PRGF) for the treatment of androgenetic alopecia (2015) (10)
Highlights and trends in cell encapsulation. (2010) (9)
Antipsychotics as environmental pollutants: An underrated threat? (2021) (9)
Plasma Rich in Growth Factors Inhibits Ultraviolet B Induced Photoageing of the Skin in Human Dermal Fibroblast Culture. (2016) (9)
Tales of biomaterials, molecules, and cells for repairing and treating brain dysfunction. (2011) (9)
Nanoclay Reinforced Biomaterials for Mending Musculoskeletal Tissue Disorders (2021) (9)
Drugs used during the COVID-19 first wave in Vitoria-Gasteiz (Spain) and their presence in the environment (2022) (9)
The influence of cellular seeding density in the microencapsulation of hybridoma cells (2005) (9)
Polymeric nanocarriers: A promising tool for early diagnosis and efficient treatment of colorectal cancer (2021) (9)
The effect of plasma rich in growth factors combined with follicular unit extraction surgery for the treatment of hair loss: A pilot study (2018) (9)
Ozone dosing alters the biological potential and therapeutic outcomes of plasma rich in growth factors. (2015) (8)
Cell-laden alginate hydrogels for the treatment of diabetes (2020) (8)
Platelet-rich plasma scaffolds for tissue engineering: More than just growth factors in three dimensions (2015) (8)
Platelet-rich plasma therapy: another appealing technology for regenerative medicine? (2016) (8)
Cell microencapsulation technologies for sustained drug delivery: Clinical trials and companies. (2020) (8)
Correlation between SARS-CoV-2 RNA concentration in wastewater and COVID-19 cases in community: A systematic review and meta-analysis (2022) (8)
Healthy and diseased in vitro models of vascular systems. (2021) (8)
Mass drug administration: time to consider drug pollution? (2020) (8)
Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy. (2022) (8)
Chitosan‐based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy (2022) (7)
A New Regulatory Framework for Platelet-Rich Plasma in Spain (2015) (7)
Force spectroscopy-based simultaneous topographical and mechanical characterization to study polymer-to-polymer interactions in coated alginate microspheres (2019) (7)
A New Era for Cyborg Science Is Emerging: The Promise of Cyborganic Beings (2019) (7)
Hazardous drugs (NIOSH's list-group 1) in healthcare settings: Also a hazard for the environment? (2022) (7)
Emerging strategies for beta cell transplantation to treat diabetes. (2021) (7)
Nontraumatic Implant Explantation: A Biomechanical and Biological Analysis in Sheep Tibia. (2016) (7)
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis (2020) (6)
Greening the pharmacy (2022) (6)
Redefining the “rational use of medicines” (2021) (6)
Recent advances in the use of encapsulated cells for effective delivery of therapeutics. (2010) (6)
Environmental pollution with psychiatric drugs (2021) (6)
The effect of selected parameters of formation on properties of alginate/Ca2+/oligochitosan capsules (2006) (6)
Protective Action of Linear Polyethylenimine against Staphylococcus aureus Colonization and Exaggerated Inflammation In vitro and In vivo. (2019) (6)
Clinical Applications of Cell Encapsulation Technology. (2020) (6)
Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF) (2018) (6)
Improved control over MSCs behavior within 3D matrices by using different cell loads in both in vitro and in vivo environments. (2017) (5)
It's about time healthcare professionals and academics start thinking about drug pollution (2020) (5)
Challenges in Cell Encapsulation (2005) (5)
Effectiveness of mobile applications to quit smoking: Systematic review and meta-analysis (2020) (5)
Engineering Hydrogels beyond a Hydrated Network (2019) (5)
Injectable and adhesive hydrogels for dealing with wounds (2021) (5)
Epo delivery by genetically engineered C2C12 myoblasts immobilized in microcapsules. (2010) (5)
The P makes the difference in plasma rich in growth factors (PRGF) technology (2011) (5)
Nanoparticle-Based Technologies for Treating and Imaging Brain Tumors. (2010) (5)
Standardizing salivary lactoferrin measurements to obtain a robust diagnostic biomarker for Alzheimer's disease (2021) (5)
Monitoring implantable immunoisolation devices with intrinsic fluorescence of genipin (2018) (5)
[Cell encapsulation for the treatment of central nervous system disorders]. (2010) (5)
Applying immunomodulation to promote longevity of immunoisolated pancreatic islet-grafts. (2021) (5)
Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines (2022) (4)
Do we really need to invoke heroic measures for early SARS-CoV-2 outbreak detection? (2020) (4)
Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases (2021) (4)
Pharmaceutical Simplification: Killing Two Birds with One Stone. (2021) (4)
Potential Effect of Plasma Rich in Growth Factors-Endoret in Stromal Wound Healing in Additive Surgery (2019) (4)
Composite alginate-gelatin hydrogels incorporating PRGF enhance human dental pulp cell adhesion, chemotaxis and proliferation. (2022) (4)
Rational use of drugs as a source control measure to fight drug pollution. (2020) (4)
Environmental contamination by pet pharmaceuticals: A hidden problem. (2021) (4)
Ivermectin & COVID-19: Let's keep a One Health perspective (2021) (4)
PRP Therapies—Is It Time for Potency Assays? Letter to the Editor (2016) (4)
3D-Printed Coaxial Hydrogel Patches with Mussel-Inspired Elements for Prolonged Release of Gemcitabine (2021) (4)
PDX-Derived Ewing’s Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures (2021) (4)
Antibacterial Activity of Small Molecules Which Eradicate Methicillin-Resistant Staphylococcus aureus Persisters (2022) (4)
Antibacterial smart hydrogels: New hope for infectious wound management (2022) (4)
3 D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies (2018) (3)
Advances in the Field of Tissue Engineering and Regenerative Medicine: State of the Art and Regulatory Issues (2013) (3)
A biological approach to orthopaedic surgery: are they lost in translation? (2013) (3)
Autologous bioscaffolds based on different concentrations of platelet rich plasma and synovial fluid as a vehicle for mesenchymal stem cells. (2018) (3)
The future of psychiatry should be One Health (2022) (3)
Healing or Not Healing. (2016) (3)
Advances in cell-laden hydrogels for delivering therapeutics (2019) (3)
Allogeneic blood-based therapies: hype or hope? (2017) (3)
Microencapsulated macrophages releases conditioned medium able to prevent epithelial to mesenchymal transition (2017) (3)
Bioencapsulation of Living Cells for Diverse Medical Applications (2018) (3)
Use of Flow Focusing Technique for Microencapsulation of Myoblasts. (2017) (2)
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients (2022) (2)
Rigorous methodology is the school of coherent conclusions in science. (2013) (2)
Venlafaxine and desvenlafaxine to be included in the surface water Watch List (2021) (2)
Progress in self-healing hydrogels and their applications in bone tissue engineering. (2022) (2)
Plasma rich in growth factors (PRGF-Endoret) in the treatment of symptomatic knee osteoarthritis: a randomized clinical trial (2012) (2)
Editorial: Recent Advances and Innovative Strategies Applied in the Development of Biomaterials. (2017) (2)
Microencapsulated Cells for Cancer Therapy. (2017) (2)
Effects of autologous serum and plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface myofibroblast differentiation. (2015) (2)
Causality in Biology Has to Answer 2 Main Questions—Which and How: Letter to the Editor (2013) (2)
Platelet-rich plasma and myofibroblasts: is the composition the key to success? (2015) (2)
Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft (2021) (2)
Low molecular‐weight hyaluronan as a cryoprotectant for the storage of microencapsulated cells (2018) (2)
Photosymbiotic tissue engineering and regeneration (2022) (2)
Shedding light on biosafety of platelet rich plasma (2017) (2)
Cell Encapsulation Technology: An Alternative Biotechnological Platform for the Treatment of Central Nervous System Diseases (2013) (2)
Clinical, radiographical, and histological outcomes of plasma rich in growth factors in extraction socket: a randomized controlled clinical trial (2014) (2)
Virus, bats and drugs (2020) (2)
Environmental risk of pharmaceuticals: Let us look at the whole package (2021) (2)
The search for new beta-cell sources. (2004) (1)
Towards a correct timing and dosage in PRP applications. (2015) (1)
INNOVATIONS IN THE USE OF BIOMATERIALS FOR TREATING BRAIN DISEASE (2010) (1)
Searching for the best blood-derived eye drops (2018) (1)
Microencapsulated cells expressing VEGF reduce brain amyloid load and behavioral impairment in Alzheimer's disease (2009) (1)
Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops at different temperature conditions for 24 hours. (2014) (1)
Response to Saiz et al., "Misreporting of a Plasma Rich in Growth Factors Trial on Knee Osteoarthritis". (2020) (1)
Estimation of illicit amphetamine consumption using wastewater based epidemiology: A tiny contribution. (2021) (1)
Mass transfer ranking of polylysine, poly-ornithine and poly-methylene-co-guanidine microcapsule membranes using a single low molecular mass marker (2003) (1)
Comparing the biological outcomes of autologous serum versus plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface wound healing. (2014) (1)
You are not walking alone in the PRP consensus road. (2014) (1)
Design of a New 3D Gelatin—Alginate Scaffold Loaded with Cannabis sativa Oil (2022) (1)
ACTIVE METHODOLOGIES FOR SOLVING CLINICAL CASES: STUDENT’S FEEDBACK (2017) (1)
Latest developments in engineered skeletal muscle tissues for drug discovery and development (2022) (1)
Cell Microencapsulation and Cryopreservation with Low Molecular Weight Hyaluronan and Dimethyl Sulfoxide. (2019) (1)
Long-Term Outcome of Transosteotomy Bone Augmentation of the Inferior Border of the Severely Resorbed Mandible (2015) (1)
Induced cell migration based on a bioactive hydrogel sheet combined with a perfused microfluidic system (2020) (1)
Induction of angiogenesis by implantation of encapsulated cells expressing vegf: A new therapy approach on Alzheimer's disease? (2009) (1)
Corrigendum to "The effect of different drugs on the preparation and biological outcomes of plasma rich in growth factors" [Ann. Anat. 196 (2014) 423-429]. (2017) (1)
Clinical efficacy of plasma rich in growth factors intra-articular infiltrations in the treatment of knee osteoarthritis: a systematic review (2014) (1)
Drug delivery technologies and stem cells for tissue repair and regeneration. (2015) (1)
Plasma rich in growth factors in dogs: Two sides of the same coin (2017) (1)
Hacking Human Beings with Machine Biology to Increase Lifespan. (2020) (1)
Three dimensional bioprinting in skeletal muscle tissue engineering (2019) (1)
Flexible Bioelectronics: Blending Electronics with the Human Body: A Pathway toward a Cybernetic Future (Adv. Sci. 10/2018) (2018) (1)
Title : 3 D cell-laden polymers to release bioactive products in the eye (2018) (1)
Corrigendum: Effectiveness of mobile applications to quit smoking: Systematic review and meta-analysis (2021) (1)
The search for new -cell sources (2004) (1)
Platelet-Rich Plasma Therapy and Antithrombotic Drugs. (2017) (1)
Platelet-rich plasma therapies: Building the path to evidence. (2017) (1)
Platelet-Rich Plasma Therapies:In the Right Pathway to Find their Regulatory Niche (2014) (1)
Solid Lipid and Polymeric Nanoparticles for Drug Delivery (2007) (1)
THE DEBATE AS A PEDAGOGICAL TOOL FROM A MULTIDISCIPLINARY APPROACH (2017) (1)
Multi-leveled Nanosilicate Implants Can Facilitate Near-Perfect Bone Healing. (2023) (0)
: Letter to the Editor How and Which − − Causality in Biology Has to Answer 2 Main Questions (2013) (0)
A perspective on bioactive cell microencapsulation. (2012) (0)
Vasomotor reactivity in mild cognitive impairment—A study with transcranial Doppler sonography (2009) (0)
Antimicrobial properties of plasma rich in growth factors ( PRGF-ENDORET ) technology (2012) (0)
A scientific journey to entrepreneurship (2019) (0)
Reply to Encapsulate this: the do's and don'ts (2014) (0)
Quantum Dots in Biomedical Applications (2019) (0)
Effect Of Plasma Rich In Growth Factors (PRGF) On Corneal Epithelial Wound Healing (2011) (0)
Corrigendum to: “Hazardous drugs (NIOSH's list-group 1) in healthcare settings: Also a hazard for the environment?” [Sci. Total Environ. 817 (2022) 152954] (2022) (0)
Towards brain-tissue-like biomaterials (2020) (0)
Cryopreservation of microencapsulated cells with low molecular weight hyaluronan (2016) (0)
Platelet-Rich Plasma to Improve the Bio-Functionality of Biomaterials (2012) (0)
Should your algorithm include plasma rich in growth factors in the light of its clinical efficacy and safety? (2015) (0)
The effect of selected parameters of formation on properties of alginate/Ca 2+ /oligochitosan (2006) (0)
Plasma rich in growth factors (PRGF) technology: simple facts that turn on the lights. (2015) (0)
Characterization of PFGR-derived fibrin scaffold interactome by 2DE and LC-MS/MS (2011) (0)
NEW APPROACHES TO THE DELIVERY OF BIOPHARMACEUTICALS (2004) (0)
3D Printed porous polyamide macrocapsule combined with alginate microcapsules for safer cell-based therapies (2018) (0)
Chapter 6 Epo Delivery by Genetically Engineered C 2 C 12 Myoblasts Immobilized in Microcapsules (0)
Cryopreservation of Human Mesenchymal Stem Cells in an Allogeneic Bioscaffold based on Platelet Rich Plasma and Synovial Fluid (2017) (0)
An allogeneic bioscaffold for the storage of human mesenchymal stem cells. (2018) (0)
PRGF-Endoret enhances stromal wound healing after additive surgery in deep stroma for 7 days (2015) (0)
PRGF-Endoret® as a substitute of Fetal Bovine Sera for the culture of human corneal limbal stem cells. (2014) (0)
PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells (2015) (0)
Comprehensive micropollutant characterization of wastewater during Covid-19 crisis in 2020: Suspect screening and environmental risk prioritization strategy (2023) (0)
Bioprinting and biomaterials for dental alveolar tissue regeneration (2023) (0)
Self‐Healable Hydrogels: Self‐Healing Hydrogels: The Next Paradigm Shift in Tissue Engineering? (Adv. Sci. 16/2019) (2019) (0)
Microencapsulated cells expressing VEGF for the treatment of Alzheimer ’ s disease (0)
Plasma Rich In Growth Factors (PRGF) Stimulate Scarness Wound Healing In The Stromal Cells Of The Ocular Surface Tissues (2011) (0)
Analyzing the potential environmental impact of NIOSH list of hazardous drugs (group 2). (2023) (0)
PRGF-Endoret® in corneal tissue engineering (2015) (0)
Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative Diseases. (2022) (0)
Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops after 3 months of storage (2013) (0)
Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering. (2022) (0)
PP-006 Galenic properties of plasma rich in growth factors eye drops (2017) (0)
Erratum to “Nanotherapeutic approaches for brain cancer management” [Nanomedicine: Nanotechnology, Biology, and Medicine 10 (2014) 905–919]. (2016) (0)
Autocrine protein expression of cells from the ocular surface after treatment with Plasma Rich in Growth Factors (PRGF-Endoret) (2012) (0)
Substitutes of fetal bovine sera for the culture of human corneal limbal stem cells (2014) (0)
Proteome study of keratocytes after PRGF-Endoret treatment (2013) (0)
Plasma Rich in Growth Factors (PRGF-Endoret) accelerates corneal wound healing after PRK eye surgery, reducing haze formation (2012) (0)
Long-term biological stability of PRGF-Endoret eye drops: effect of temperature and dosage (2015) (0)
PP-007 Development and characterisation of a plasma rich in growth factors membrane to treat ocular surface diseases (2017) (0)
Reinforcement of Calcium Phosphate Cement with Hybrid Silk Fibroin/Kappa-Carrageenan Nanofibers (2023) (0)
[Translated article] A more sustainable pharmacy. (2023) (0)
Emerging immunomodulatory strategies for cell therapeutics. (2022) (0)
PRGF-Endoret®: A new approach in the treatment of limbal stem cell deficiency. (2016) (0)
Platelet-rich therapies as an emerging platform for regenerative medicine (2021) (0)
Growth factor and fibrin scaffold properties are influenced by the inclusion of white blood cells in platelet-rich plasma (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gorka Orive?

Gorka Orive is affiliated with the following schools:

University of the Basque Country